ArticleLeukemia2008

RNAi-mediated silencing of p190Bcr-Abl inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190Bcr-Abl-expressing leukemia cells.

M Futami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.